Dr. James F. Mcmanus, DDS in Warwick, Rhode Island

Info
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • Dentist

  • Pratt Family Dentistry

  • Judy Pratt, D.M.D.

  • Dr. James F. Mcmanus, DDS

  • Michael Jay Harris, D.D.S.

  • East Greenwich Dental Associates

  • |
    Understanding Robert F. Kennedy Jr.’s Impact on Vaccine Views and Public Health Policy

    The article “Understanding Robert F. Kennedy Jr.’s Impact on Vaccine Views and Public Health Policy” examines Kennedy’s history of vaccine skepticism and the spread of health misinformation, highlighting how his influence could shape public health policies in ways that may undermine trust in vaccines and established medical guidance. By analyzing his track record, the article helps readers recognize the importance of reliable health information when making decisions about health insurance plans, benefits, and costs. Understanding the potential risks of misinformation empowers individuals to choose insurance options that prioritize evidence-based care and comprehensive coverage, ultimately supporting better health outcomes and more informed choices.

  • Aurora Sheboygan Prices – HEPATITIS BE AB is $125

    At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001408, regarding HEPATITIS BE AB, which is classified under revenue code 302 and associated with CPT code 86707, the designated fee stands at $125. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • |
    Obsessive-Compulsive Disorder (OCD): Management Strategies

    In conclusion, effective management of Obsessive-Compulsive Disorder (OCD) requires a comprehensive, multifaceted approach. Cognitive-behavioral therapy, particularly Exposure and Response Prevention (ERP), has demonstrated significant efficacy in reducing symptoms. Pharmacological interventions, primarily selective serotonin reuptake inhibitors (SSRIs), offer additional support, particularly for those with moderate to severe symptoms. Emerging treatments, such as deep brain stimulation and mindfulness-based therapies, provide promising avenues for future research and clinical application. Ultimately, a personalized treatment plan, developed in collaboration with healthcare professionals, remains crucial for optimizing outcomes and enhancing the quality of life for individuals with OCD. Continued advancements in understanding and treating OCD will undoubtedly contribute to more effective and accessible care in the years to come.